-+ 0.00%
-+ 0.00%
-+ 0.00%
Vector Science and Therapeutics Partners With Andrews Foundation on Peptide Research for Sports Medicine
Share
Listen to the news
Vector Science and Therapeutics Partners With Andrews Foundation on Peptide Research for Sports Medicine
  • Vector Science and Therapeutics announced a collaboration with Andrews Research & Education Foundation to develop peptides for sports and regenerative medicine.
  • Planned clinical programs will evaluate soft-tissue repair, muscle regeneration in aging athletes and degenerative osteoarthritis.
  • The foundation will contribute research and intellectual property; Vector will formulate, manufacture and test pharmaceutical-grade peptides.
  • New intellectual property will be jointly owned; Vector will lead product commercialization through direct-to-physician marketing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vector Science and Therapeutics Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611180730PR_NEWS_USPR_____LA00647) on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending